Akebia To Host Conference Call On March 14th To Discuss Full-Year 2015 Financial Results And Corporate Highlights

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that it will host a conference call on Monday, March 14, 2016 at 4:30 PM ET to discuss the financial results for the year ended December 31, 2015, and recent corporate highlights.